期刊文献+

The Expression of Resistin in Adipose Tissues of Patients with Polycystic Ovary Syndrome and Insulin Resistance 被引量:5

The Expression of Resistin in Adipose Tissues of Patients with Polycystic Ovary Syndrome and Insulin Resistance
暂未订购
导出
摘要 The relationship between the expression of resistin in polycystic ovary syndrome (PCOS) and insulin resistance was investigated. The plasma resistin concentrations in 35 patients with PCOS and 40 controls were measured by ELISA. Luteinizing hormone (LH), follicle-stimulating hormone (FSH), and fasting insulin (FIN) were tested by radioimmunoassay. Insulin resistance index (HOMA-IR) was calculated. Fasting plasma glucose (FPG) was determined by oxidase test. Western blot and reverse transcriptase PCR (RT-PCR) methods were used to detect the expression of resistin in adipose tissues. The levels of plasma resistin, LH, LH/FSH and FIN and HOMA-IR in patients with PCOS were significantly higher than those in control group (all P〈0.05). Plasma resistin was correlated positively with FPG, FIN, HOMA-IR, LH and LH/FSH (r=0.56, 0.60, 0.65, 0.48, and 0.42 respectively). Resistin protein and mRNA expression levels in patients with PCOS were significantly higher than those in normal tissues (all P〈0.01). It was concluded that resistin might be involved in the pathogenesis of insulin resistance of PCOS. The relationship between the expression of resistin in polycystic ovary syndrome (PCOS) and insulin resistance was investigated. The plasma resistin concentrations in 35 patients with PCOS and 40 controls were measured by ELISA. Luteinizing hormone (LH), follicle-stimulating hormone (FSH), and fasting insulin (FIN) were tested by radioimmunoassay. Insulin resistance index (HOMA-IR) was calculated. Fasting plasma glucose (FPG) was determined by oxidase test. Western blot and reverse transcriptase PCR (RT-PCR) methods were used to detect the expression of resistin in adipose tissues. The levels of plasma resistin, LH, LH/FSH and FIN and HOMA-IR in patients with PCOS were significantly higher than those in control group (all P〈0.05). Plasma resistin was correlated positively with FPG, FIN, HOMA-IR, LH and LH/FSH (r=0.56, 0.60, 0.65, 0.48, and 0.42 respectively). Resistin protein and mRNA expression levels in patients with PCOS were significantly higher than those in normal tissues (all P〈0.01). It was concluded that resistin might be involved in the pathogenesis of insulin resistance of PCOS.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第5期642-645,共4页 华中科技大学学报(医学英德文版)
基金 supported by a grant from the Science and Technology Planning Project of Yantai,China (No.2004221)
关键词 polyeystic ovary syndrome RESISTIN fasting plasma glucose fasting insulin insulin resistance polyeystic ovary syndrome resistin fasting plasma glucose fasting insulin insulin resistance
  • 相关文献

参考文献10

  • 1Burghen GA,Givens JR,Kitabchi AE.Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease[].Journal of Clinical Endocrinology and Metabolism.1980
  • 2Rajala MW,Obici S,Scherer PE,et al.Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production[].Journal of Clinical Investigation The.2003
  • 3McTernan CL,McTernan PG,Harte AL,et al.Resistin, central obesity, and type 2 diabetes[].The Lancet.2002
  • 4Savage DB,Sewter CP,Klenk ES,et al.Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptorgamma action in humans[].Diabetes.2001
  • 5Kok-Min Seow,Chi-Chang Juan,Liang-Yi Wu,et al.Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance[].Human Reproduction.2004
  • 6Wang H,Chu WS,Hemphill C,et al.Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians[].Journal of Clinical Endocrinology and MetabolismThe.2002
  • 7Sentinelli F,Romeo S,Arca M,et al.Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study[].Diabetes.2002
  • 8Spiegelman BM.PPAR-gamma: adipogenic regulator and thiazolidinedione receptor[].Diabetes.1998
  • 9Ling C,Kindblom J,Wennbo H,et al.Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels[].FEBS Letters.2001
  • 10Nestler J E,Jakubowicz D J,Evans W S,et al.Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome[].New England Journal of Medicine The.1998

同被引文献153

  • 1陈子江,李媛,周灿权,黄荷凤,刘嘉茵,乔杰,黄国宁,梁晓燕,郁琦.多囊卵巢综合征与辅助生殖的热点问题讨论[J].现代妇产科进展,2004,13(4):241-250. 被引量:58
  • 2张晓红,杨正望,尤昭玲.补肾中药对卵巢功能及子宫内膜的影响[J].中医药学刊,2005,23(11):2054-2055. 被引量:70
  • 3黄卫娟,刘嘉茵,李丽娜.环境因素与多囊卵巢综合征发病的相关性分析[J].中华妇产科杂志,2007,42(5):302-304. 被引量:46
  • 4陈小玲,黄水莲.多囊卵巢综合征的研究进展[J].中国误诊学杂志,2007,7(15):3459-3462. 被引量:14
  • 5Ovalle F,Azziz R.Insulin resistance, polysystic ovary syndrome, and type 2 diabetes mellitusFertility and Sterility,2002.
  • 6Glintborg D,Hermann AP,Andersen M,et al.Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndromeFertility and Sterility,2006.
  • 7El-Mazny A,Abou-Salem N,El-Sherbiny W.Insulin resistance,dyslipidemia,and metabolic syndrome in women with polycystic ovary syndromeInternational Journal of Gynaecology and Obstetrics,2010.
  • 8Knowler WC;Barrett-Connor E;Fowler SE.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,2002(06).
  • 9Gillett MJ.International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Clin Biochem Rev . 2009
  • 10Coviello AD,Sam S,Legro RS,Dunaif A.High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. The Journal of Clinical Endocrinology . 2009

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部